Timing of follow-up after abnormal screening and diagnostic mammograms

American Journal of Managed Care

Volumn 17, Issue 2, 2011, Pages 162-167

  Wernli, Karen J ^a   Aiello Bowles, Erin J ^a   Haneuse, Sebastien ^a   Elmore, Joanne G ^b   Buist, Diana S M ^a  

^a GROUP HEALTH RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER SCREENING; DIAGNOSTIC TEST; FEMALE; FOLLOW UP; HEALTH CARE SYSTEM; HEALTH PROGRAM; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OBESITY; PRIORITY JOURNAL;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; DELIVERY OF HEALTH CARE, INTEGRATED; FEMALE; FOLLOW-UP STUDIES; HUMANS; INSURANCE, HEALTH; LOGISTIC MODELS; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; RETROSPECTIVE STUDIES; RISK FACTORS; SOCIOECONOMIC FACTORS; TIME FACTORS; WASHINGTON;

EID: 79960228096     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Centers for Disease Control and Prevention (CDC). Use of mammograms among women age > or = 40 years - United States, 2000-2005. MMWR Morb Mortal Wkly Rep. 2007;56(3):49-51.
2. Rosenberg RD, Yankaskas BC, Abraham LA, et al. Performance benchmarks for screening mammography. Radiology. 2006;241(1):55-66. (Pubitemid 44433335)
3. Sickles EA, Miglioretti DL, Ballard-Barbash R, et al. Performance benchmarks for diagnostic mammography. Radiology. 2005;235(3):775-790. (Pubitemid 40695870)
4. Battaglia TA, Roloff K, Posner MA, Freund KM. Improving follow-up to abnormal breast cancer screening in an urban population. A patient navigation intervention. Cancer. 2007;109(2 suppl):359-367.
5. Jones BA, Dailey A, Calvocoressi L, et al. Inadequate follow-up of abnormal screening mammograms: findings from the race differences in screening mammography process study (United States). Cancer Causes Control. 2005;16(7):809-821. (Pubitemid 41166546)
6. Burack RC, Simon MS, Stano M, George J, Coombs J. Follow-up among women with an abnormal mammogram in an HMO: is it complete, timely, and efficient? Am J Manag Care. 2000;6(10):1102-1113.
7. Ganry O, Peng J, Dubreuil A. Influence of abnormal screens on delays and prognostic indicators of screen-detected breast carcinoma. J Med Screen. 2004;11(1):28-31. (Pubitemid 38365692)
8. Gold HT, Do HT, Dick AW. Correlates and effect of suboptimal radiotherapy in women with ductal carcinoma in situ or early invasive breast cancer. Cancer. 2008;113(11):3108-3115.
9. Hershman DL, Wang X, McBride R, Jacobson JS, Grann VR, Neugut AI. Delay of adjuvant chemotherapy initiation following breast cancer surgery among elderly women. Breast Cancer Res Treat. 2006;99(3):313-321. (Pubitemid 44337924)
10. Weinmann S, Taplin SH, Gilbert J, et al. Characteristics of women refusing follow-up for tests or symptoms suggestive of breast cancer. J Natl Cancer Inst Monogr. 2005(35):33-38.
11. Rojas M, Mandelblatt J, Cagney K, Kerner J, Freeman H. Barriers to follow-up of abnormal screening mammograms among low-income minority women. Cancer Control Center of Harlem. Ethn Health. 1996;1(3):221-228.
12. McCarthy BD, Yood MU, Boohaker EA, Ward RE, Rebner M, Johnson CC. Inadequate follow-up of abnormal mammograms. Am J Prev Med. 1996;12(4):282-288. (Pubitemid 26303473)
13. Juarbe TC, Kaplan CP, Somkin CP, Pasick R, Gildengorin G, Pérez-Stable EJ. Are risk factors for breast cancer associated with follow-up procedures in diverse women with abnormal mammography? Cancer Causes Control. 2005;16(3):245-253.
14. Press R, Carrasquillo O, Sciacca RR, Giardina EG. Racial/ethnic disparities in time to follow-up after an abnormal mammogram. J Womens Health (Larchmt). 2008;17(6):923-930.
15. Caplan LS, May DS, Richardson LC. Time to diagnosis and treatment of breast cancer: results from the National Breast and Cervical Cancer Early Detection Program, 1991-1995. Am J Public Health. 2000;90(1):130-134.
16. American College of Radiology. Breast Imaging Reporting and Data System Atlas (BI-RADS® Atlas). Reston, VA: American College of Radiology; 2003.
17. Taplin SH, Ichikawa L, Buist DS, Seger D, White E. Evaluating organized breast cancer screening implementation: the prevention of late-stage disease? Cancer Epidemiol Biomarkers Prev. 2004;13(2):225-234.
18. Group Health Research Institute. Breast Cancer Surveillance, Group Health Research Institute. 2008. http://www.grouphealthresearch.org/ surveillanceproject/default.htm. Accessed June 2, 2010.
19. Agresti A. Categorical Data Analysis. Hoboken, NJ: Wiley-Interscience; 2002.
20. Karliner LS, Kaplan CP, Juarbe T, Pasick R, Pérez-Stable EJ. Poor patient comprehension of abnormal mammography results. J Gen Intern Med. 2005;20(5):432-437. (Pubitemid 40980443)
21. Mandelson MT, Oestreicher N, Porter PL, et al. Breast density as a predictor of mammographic detection: comparison of interval- and screen-detected cancers. J Natl Cancer Inst. 2000;92(13):1081-1087. (Pubitemid 30616482)
22. Kerlikowske K. Timeliness of follow-up after abnormal screening mammography. Breast Cancer Res Treat. 1996;40(1):53-64. (Pubitemid 26283490)
23. Monticciolo DL, Sickles EA. Computerized follow-up of abnormalities detected at mammography screening. AJR Am J Roentgenol. 1990;155(4):751-753. (Pubitemid 20305033)
24. Malin JL, Schneider EC, Epstein AM, Adams J, Emanuel EJ, Kahn KL. Results of the National Initiative for Cancer Care Quality: how can we improve the quality of cancer care in the United States [published correction appears in J Clin Oncol. 2006;24(12):1966]? J Clin Oncol. 2006;24(4):626-634. (Pubitemid 46630426)
25. Kaufman CS. National quality validation programs for breast centers. Expert Rev Anticancer Ther. 2007;7(10):1357-1362. (Pubitemid 351826902)